Severe Infection Clinical Trial
Official title:
Nutritional Supplement for Patients With Severe Infection
This is a randomized trial testing a supplement that has been approved by Health Canada to support healthy cholesterol levels (i.e. high density lipoprotein (HDL) cholesterol). This trial is proposing to use this approved supplement to determine whether it is able to raise HDL cholesterol in patients treated in the intensive care unit (ICU) with severe infection who have detrimentally low levels of HDL cholesterol. Patients who present to the ICU with severe infection will be approached for consent. If they choose to participate, patients will be given usual care or a 150mL daily nutritional supplement containing lauric acid (15 ml) and Berberine (1000 mg) daily for 14 days. Participants will be followed during their stay in the ICU and will receive follow up phone calls at Day 28 and 90.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04990908 -
Systematic Screening for Primary Immunodeficiencies in Patients Admitted for Severe Infection in Pediatric Intensive Care Unit
|
||
| Recruiting |
NCT05788861 -
Invasive Group A Streptococcal Infection
|
||
| Active, not recruiting |
NCT02846298 -
Evaluation of Pharmacokinetic / Pharmacodynamic Data and Interest Individualized Therapeutic Drug Monitoring Glycopeptides and β-lactam-aminoglycoside ICU
|
||
| Recruiting |
NCT04650607 -
Phage Safety Cohort Study
|
||
| Recruiting |
NCT02167802 -
Construction and Validation of a Tool for Automatic Identification of Care Pathways at Risk of Sub-optimality in the Management of Severe Infections in Children (DIABACT IV)
|
||
| Completed |
NCT03145428 -
Evaluation of Monocyte Volume Distribution Width (MDW) for Early Detection of Sepsis
|
||
| Terminated |
NCT05210387 -
Seven Versus 14 Days of Antibiotic Therapy for Multidrug-resistant Gram-negative Bacilli Infections
|
N/A | |
| Recruiting |
NCT06260345 -
CommunautAry Pediatric bacteRial Infection in Intensive CarE Unit
|
||
| Recruiting |
NCT06161870 -
Clinical Study of Individualized Vancomycin Dosing Based on Population PK Model
|
Phase 4 | |
| Completed |
NCT04621539 -
Validation of the Quick Sequential [Sepsis-related] Organ Failure Assessment (qSOFA) in Obstetric Patients
|
||
| Recruiting |
NCT06185920 -
PHAGEinLYON Clinic Cohort Study: a Descriptive Study of Severe Infections Treated With Phage Therapy at the HCL.
|
||
| Recruiting |
NCT04923828 -
Chinese PICU Collaborative Network on Pathogens and Drug Resistance of Severe Infections
|
||
| Completed |
NCT03588325 -
Evaluation of MDW for Early Detection of Sepsis, Clinical Validity
|